Those minimal invasive examinations have significantly improved lung cancer diagnosis; however, small samples and cytologic specimens were sometimes not sufficient of quality or quantity for EGFR mutation testing in which the reported failure rates are about 5% to 30% [39–41]. This evidence concerns the gene EGFR and lung carcinoma.